Research suggests that elderberry may offer some benefit to immune-related outcomes, though the current evidence base is quite limited. A small open-label randomized clinical trial found that a standardized elderberry extract was associated with greater reductions in lingering post-COVID symptoms and improved quality of life compared to standard care alone, lending modest support to elderberry's role in recovery and immune function. A separate crossover trial examined a broader plant bioactive-rich diet — of which elderberry compounds are one component — and found changes in gut microbial metabolism rather than dramatic shifts in microbiome composition, though this study was not specific to elderberry and its findings are only indirectly relevant. Overall, the available evidence consists of early-stage, small-scale trials with notable methodological limitations such as open-label designs and limited sample sizes, meaning firm conclusions about elderberry's effects on immune function cannot yet be drawn.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Potential use of Immunodaat® (Botanical extract of Elderberry -Sambucus Nigra... | Other | 2022 | Supports | 90 |
| Dietary bioactives increase gut microbiome diversity and alter host and micro... | Other | 2025 | Neutral | 85 |